Improved Blood Sugar Control: Enhances insulin sensitivity and lowers blood glucose levels, making it promising for type 2 diabetes treatment
It is not approved for human or animal use, and may not be used in food, drugs, cosmetics, or diagnostic applications
Could WADA eventually ban GLP-1s
Neurologically, BPC-157 normalises dopamine and serotonin receptor expression disrupted by neurotoxic challenges in animal models, and has shown attenuation of serotonin syndrome and dopaminergic injury via vagal-brain axis signalling
Understanding the distinctions in absorption, effectiveness, convenience, and cost is key to making an informed decision with your healthcare provider
Other peptides, such as sermorelin, are included on the FDAs 503A Bulks List, also called Category 1